文献速递心外重症与机械循环支持

老年难治性心源性休克患者静脉-动脉体外膜氧合的应用趋势与结局:ELSO登记分析

Venoarterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock in Elderly Patients: Trends in Application and Outcome From the Extracorporeal Life Support Organization (ELSO) Registry.
PubMed 文献 · Ann Thorac Surg · 2017-01-26

基于ELSO登记数据,分析1992至2015年因难治性心源性休克接受VA-ECMO的成人患者,比较老年(≥70岁)与年轻(18-<70岁)患者的院内生存与并发症。老年组占13.6%,院内生存率30.5%低于年轻组43.1%(p<0.001),多器官衰竭率更高,多变量分析显示年龄是院内生存的独立负性预测因子,但作者认为高龄本身不应视为绝对禁忌。

要点

  • 老年患者VA-ECMO院内生存率30.5%,低于年轻患者43.1%(p<0.001)。
  • 老年组多器官衰竭率更高,年龄是院内生存独立负性预测因子。
  • 高龄本身不应作为VA-ECMO的绝对禁忌证。

核心结论

  • 基于可接受的院内生存率,高龄本身不应视为VA-ECMO支持治疗难治性心源性休克的绝对禁忌证。

研究设计与样本

  • 回顾性分析ELSO登记数据,纳入1992至2015年因难治性心源性休克接受VA-ECMO的成人患者共5408例。
  • 老年组为≥70岁患者735例(13.6%),年轻组为≥18至<70岁患者4673例,比较院内生存与并发症。

主要发现

  • 总体成人队列院内生存率为41.4%(2240/5408),老年组为30.5%(224/735),年轻组为43.1%(2016/4673),p<0.001。
  • 老年组VA-ECMO平均持续时间101±91小时,年轻组为138±146小时(p<0.001)。
  • 老年组接受ECMO前心脏手术者134例(18.9%),因心脏术后支持接受VA-ECMO者占2.2%,年轻组为0.7%。
  • 老年组多器官衰竭发生率更高,多变量分析显示年龄是院内生存的独立负性预测因子。

临床怎么用

  • 在考虑VA-ECMO支持难治性心源性休克时,不应仅因高龄而绝对排除老年患者。
  • 对老年患者应充分评估多器官衰竭风险,并个体化决策VA-ECMO支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) for refractory cardiogenic shock (RCS) is increasingly used in adult patients, but age represents a controversial factor in this setting. METHODS: Data from the Extracorporeal Life Support Organization registry was analyzed to assess in-hospital survival of elderly patients (≥70 years of age) undergoing VA-ECMO for RCS from 1992 to 2015. In-hospital survival and complications for elderly patients were compared with data in younger adults (≥18 to <70 years of age) supported with VA-ECMO during the same time period for similar indications. RESULTS: The mean age of the patient cohort (n = 5,408) was 53.0 ± 15.7 years (range, 18 to 91 years). The elderly group included 735 patients (13.6%), with a mean age of 75.2 ± 4.4 years. In the elderly group, pre-ECMO cardiac procedures were performed in 134 cases (18.9%), and 2.2% received VA-ECMO for postcardiotomy support compared with 0.7% in the younger cohort. The mean duration of VA-ECMO in the elderly group was 101 ± 91 h compared with 138 ± 146 h in the younger group (p < 0.001). Overall, survival to hospital discharge for the entire adult cohort was 41.4% (2,240 of 5,408), with 30.5% (224 of 735) in the elderly patient group and 43.1% (2,016 of 4,673) in the younger patient group (p < 0.001). Elderly patients had a higher rate of multiorgan failure. At multivariable analysis age represented an independent negative predictor of in-hospital survival. CONCLUSIONS: Based on the acceptable survival to hospital discharge in our study, older age alone should not represent an absolute contraindication when considering VA-ECMO support for RCS.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Lorusso R, Gelsomino S, Parise O, et al. Venoarterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock in Elderly Patients: Trends in Application and Outcome From the Extracorporeal Life Support Organization (ELSO) Registry. Ann Thorac Surg. 2017. PMID: 28131429. doi:10.1016/j.athoracsur.2016.10.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。